Jane Henderson

Director

Jane Henderson (Director) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in Apogee Therapeutics, Inc. (APGE). The largest single filing was $609K of APGE (8,000 sh across 3 lots, as filed), executed Jan 2.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 7 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$1.4M

shares × price, as filed

Last traded

Apr 16

Filed Apr 17

Median ADV $371.2M across their filed names

Open performance→

Volume by month

Buys $0 Sells $1.6M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 7 filings

Sector per market data · by filing · past 12 months

Most traded names

APGE

Apogee Therapeutics, Inc. APGE · 0 buys · 7 sells 7 filings AKRO AKRO AKRO · 0 buys · 1 sell 1 filing

Recent filings

APGESALE Apogee Therapeutics, Inc. View filing → $180K
2,000 sh × $90.00
Exec Apr 16
Filed Apr 17 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. View filing → $170K
2,000 sh × $85.00
Exec Mar 25
Filed Mar 27 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. View filing → $609K
8,000 sh across 3 lots
Exec Jan 2
Filed Jan 6 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. View filing → $120K
1,500 sh × $80.00
Exec Dec 19 2025
Filed Dec 23 2025 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. View filing → $112K
1,500 sh × $75.00
Exec Dec 4 2025
Filed Dec 5 2025 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. View filing → $105K
1,500 sh × $70.00
Exec Nov 25 2025
Filed Nov 28 2025 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. View filing → $130K
2,000 sh × $65.00
Exec Nov 14 2025
Filed Nov 14 2025 · 5:30 PM ET AKROSALE Akero Therapeutics, Inc. View filing → $142K
3,000 sh × $47.46
Exec Aug 12 2025
Filed Aug 12 2025 · 5:30 PM ET